$0.5301
-0.03-5.34%
At close: -
$0.4915
-0.04-7.28%
After Hours: Jan 17, 5:04 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for ImmunoPrecise Antibodies in recent months.
Browse guidance and forecast on all stocks.